Covered recipient · General Payments record
PAUL MATHEW SWANSON
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$5,445.02
- Reported across 354 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.36 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $44.10 | 2 |
| Kite Pharma, Inc. | $41.87 | 2 |
| Gilead Sciences, Inc. | $36.09 | 2 |
| ABBVIE INC. | $20.19 | 1 |
| GlaxoSmithKline, LLC. | $17.59 | 1 |
| Janssen Biotech, Inc. | $14.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.19 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106188480 | CMS |
| Gilead Sciences, Inc. | $17.94 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133797583 | CMS |
| Gilead Sciences, Inc. | $18.15 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133797585 | CMS |
| GlaxoSmithKline, LLC. | $17.59 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116611645 | CMS |
| Incyte Corporation | $27.15 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141273410 | CMS |
| Incyte Corporation | $16.95 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141276932 | CMS |
| Janssen Biotech, Inc. | $14.52 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078512076 | CMS |
| Kite Pharma, Inc. | $26.97 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128611739 | CMS |
| Kite Pharma, Inc. | $14.90 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128611737 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.